FORTE BIOSCIENCES, INC. (FBRX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $6.34 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2020-02-27

• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-03-31 was $1.00M, a 400.00% increase year-over-year.
• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2016-03-31 was $200.00K.
• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $6.34M, a 0.28% increase from fiscal 2018.
• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $6.32M, a 187.97% increase from fiscal 2017.
• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $2.19M, a 101.84% increase from fiscal 2016.
• FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2016 was $1.09M, a 26.10% increase from fiscal 2015.